Results 131 to 140 of about 11,601 (177)
Some of the next articles are maybe not open access.
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2006
Docetaxel is a semisynthetic taxane indicated for the treatment of advanced breast, prostate, and non–small cell lung cancers; it is also used for the treatment of various other solid tumors. The standard intermittent dosage of docetaxel is 60–100 mg/m2 every 3 weeks.
Polly E, Kintzel +2 more
openaire +2 more sources
Docetaxel is a semisynthetic taxane indicated for the treatment of advanced breast, prostate, and non–small cell lung cancers; it is also used for the treatment of various other solid tumors. The standard intermittent dosage of docetaxel is 60–100 mg/m2 every 3 weeks.
Polly E, Kintzel +2 more
openaire +2 more sources
British Journal of Plastic Surgery, 1993
Current management concepts of epiphora in established facial palsy are reviewed and compared with those advocated by McLaughlin and criticized by Stallard in 1949.
openaire +2 more sources
Current management concepts of epiphora in established facial palsy are reviewed and compared with those advocated by McLaughlin and criticized by Stallard in 1949.
openaire +2 more sources
The relief of epiphora by conjunctivorhinostomy
Journal of Small Animal Practice, 1975ABSTRACTA technique of conjunctivorhinostomy is described for the relief of epiphora in the absence of satisfactory lachrymal drainage. The method employed involves implanting a polythene tube from the mesial canthus to the maxillary sinus to create a permanent fistula.
openaire +2 more sources
Sponge Attachment for Epiphora
Archives of Ophthalmology, 1957A simple method for relieving epiphora is the attachment of an absorbent sponge to the patient's glasses so that it lightly touches the inner canthus. This should be beneficial for any type of tearing except in those cases which are due to inflammation.
openaire +2 more sources
Functional epiphora: an under-reported entity
International Ophthalmology, 2023Eiman Usmani +2 more
exaly

